Close Menu

lymphoma

Diagnovus this week launched Engauge-Cancer-DLBCL, a gene expression assay designed to aid physicians with risk stratification and treatment of patients with diffuse large B-cell lymphoma.

Epizyme this week announced a collaboration with Eisai and Roche to develop an in vitro, PCR-based companion diagnostic test to help treat genetically defined lymphomas.

Researchers from Epizyme and elsewhere have reported that the company's investigational compound EPZ5687 targets and destroys lymphoma cells harboring mutations in EZH2, a type of histone-modifying enzyme.

NEW YORK (GenomeWeb News) – PrimeraDx has landed a grant from the National Cancer Institute to develop a gene expression profiling assay that can rapidly detect diffuse large B-Cell lymphoma (DLBCL) subgroups, making it easier to diagnose the disease, select treatment options, and predict the lik

NEW YORK (GenomeWeb News) – Researchers at Mayo Clinic and the University of Iowa have received an $11.5 million grant from the National Cancer Institute to fund translational and clinical projects focused on lymphoma, including genomics-based research.

Sequenta's sequencing assay to measure residual disease is now being tested in two clinical trials for mantle cell lymphoma.

NEW YORK (GenomeWeb News) – An international team led by investigators at the National Institutes of Health has identified new pathogenic pathways in a form of non-Hodgkin's lymphoma called Burk

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund researchers seeking to develop and validate biomarkers that can be used to detect and predict progression of hematopoietic malignancies, such as Hodgkin and non-Hodgkin lymphoma, leukemia, multiple myeloma, and others.

AssureRx Launches GeneSightRx ADHD
AssureRx Health this week launched a pharmacogenetic test, called GeneSightRx ADHD, for characterizing patients' response to a variety of attention deficit hyperactivity disorder drugs.

Pages

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.